These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35758433)

  • 21. LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution.
    Zhang M; Fang R; Mou Y; Chen R; Xu X; Zhang R; Yan J; Jin W; Ajoodhea H
    BMC Gastroenterol; 2015 Dec; 15():182. PubMed ID: 26695506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.
    Cienfuegos JA; Salguero J; Núñez-Córdoba JM; Ruiz-Canela M; Benito A; Ocaña S; Zozaya G; Martí-Cruchaga P; Pardo F; Hernández-Lizoáin JL; Rotellar F
    Surg Endosc; 2017 Oct; 31(10):3847-3857. PubMed ID: 28127714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
    Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
    J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group.
    Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Schmidt CR; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Aug; 120(2):231-240. PubMed ID: 31001868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
    Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
    HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
    Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
    Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors.
    Altimari M; Abad J; Chawla A
    HPB (Oxford); 2021 Oct; 23(10):1533-1540. PubMed ID: 33832835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic distal pancreatectomy for pancreatic cancer is safe and effective.
    Bauman MD; Becerra DG; Kilbane EM; Zyromski NJ; Schmidt CM; Pitt HA; Nakeeb A; House MG; Ceppa EP
    Surg Endosc; 2018 Jan; 32(1):53-61. PubMed ID: 28643065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections.
    Hackert T; Hinz U; Fritz S; Strobel O; Schneider L; Hartwig W; Büchler MW; Werner J
    Langenbecks Arch Surg; 2011 Dec; 396(8):1197-203. PubMed ID: 21553230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
    Sallinen V; Haglund C; Seppänen H
    Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic Outcomes of Robotic Left Pancreatectomy for Pancreatic Adenocarcinoma: A Single-Center Comparison to Laparoscopic Resection.
    Baimas-George M; Watson M; Salibi P; Tschuor C; Murphy KJ; Iannitti D; Baker E; Ocuin L; Vrochides D; Martinie JB
    Am Surg; 2021 Jan; 87(1):45-49. PubMed ID: 32915060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
    Chopde A; Gupta A; Chaudhari V; Parghane R; Basu S; Ostwal V; Ramaswamy A; Puranik A; Shrikhande SV; Bhandare MS
    Langenbecks Arch Surg; 2023 May; 408(1):204. PubMed ID: 37212896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Enucleation of pancreatic tumors: a multiple-center study].
    Solodkiy VA; Kriger AG; Akhaladze GG; Goev AA; Goncharov SV; Gorin DS; Zagainov VE; Kuznetsov NS; Kuchin DM; Latkina NV; Lysanyuk MV; Maistrenko NA; Martirosyan TA; Romashchenko PN; Shuinova EA; Yukina MY
    Khirurgiia (Mosk); 2023; (2):13-20. PubMed ID: 36748866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
    Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
    Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
    Gudmundsdottir H; Pery R; Graham RP; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Habermann EB; Nagorney DM; Cleary SP
    Ann Surg Oncol; 2022 Oct; 29(11):6949-6957. PubMed ID: 35731358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.